海创药业: 中信证券股份有限公司关于海创药业股份有限公司首次公开发行部分限售股上市流通的核查意见

Core Viewpoint - The report from CITIC Securities provides a thorough review of the restricted shares of Haichuang Pharmaceutical Co., Ltd. that are set to be listed for trading, confirming compliance with relevant regulations and the fulfillment of commitments by shareholders [1][5]. Group 1: Restricted Shares Overview - The total number of restricted shares to be listed is 8,790,661 shares, which represents 8.8780% of the company's total share capital [3][4]. - The listing date for these restricted shares is April 14, 2025, due to April 12, 2025, being a non-trading day [3][4]. Group 2: Shareholder Commitments - Shareholders, including Chengdu Haichuang Tongli Enterprise Management Center (Limited Partnership), Hinova United LLC, and Amhiron LLC, have committed not to transfer or manage the restricted shares for 36 months from the date of the company's stock listing [2]. - The shareholders have also agreed that any reduction in their holdings after the lock-up period will not exceed the legal limits set by regulations [2]. Group 3: Compliance and Verification - CITIC Securities confirms that the shareholders have adhered to their commitments regarding the restricted shares, and the listing of these shares complies with the Company Law, Securities Law, and other relevant regulations [5].